68ga-lnc1007
Healthy Volunteers
Yantai LNC Biotechnology Singapore PTE. LTD.radiopharmaceuticalPhase 1Active
CC
44/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 81/ 100
Competitive context
64 Active assets in the Healthy Volunteers cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Semaglutide Novo Nordisk A/S | Phase 4 | BB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE National Institute of Mental Health (NIMH) | Phase 4 | BB |
Alpha-1-Proteinase Inhibitor Baxalta now part of Shire | Phase 4 | BB |
DULAGLUTIDE Novo Nordisk A/S | Phase 4 | BB |
Risperdal University of Manchester | Phase 4 | BB |
View all 50 →
Same molecule, other indications
68ga-lnc1007 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →